当前位置:首页 - 行情中心 - 澳洋健康(002172) - 财务分析 - 现金流量表

澳洋健康

(002172)

  

流通市值:30.30亿  总市值:30.32亿
流通股本:7.65亿   总股本:7.66亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,175,130,526.65812,109,565.37309,625,785.381,879,837,176.46
  收到的税费返还439,253.38439,253.38--
  收到其他与经营活动有关的现金184,582,195.03177,237,242.06171,420,842.63306,828,472.31
  经营活动现金流入小计1,360,151,975.06989,786,060.81481,046,628.012,186,665,648.77
  购买商品、接受劳务支付的现金906,987,403.55660,890,477.91367,526,402.441,538,716,255.03
  支付给职工以及为职工支付的现金240,803,380.41164,737,870.7993,354,636.78319,133,122.48
  支付的各项税费43,535,057.7631,349,142.8217,561,197.754,512,958.68
  支付其他与经营活动有关的现金197,481,556.65187,936,403.81182,545,096.88273,864,660.95
  经营活动现金流出小计1,388,807,398.371,044,913,895.33660,987,333.82,186,226,997.14
  经营活动产生的现金流量净额-28,655,423.31-55,127,834.52-179,940,705.79438,651.63
二、投资活动产生的现金流量:
  收回投资收到的现金2---
  处置固定资产、无形资产和其他长期资产收回的现金净额39,42039,12066,697.9627,704.18
  投资活动现金流入小计39,42239,12066,697.9627,704.18
  购建固定资产、无形资产和其他长期资产支付的现金29,543,595.4418,595,089.5916,332,745.3428,639,622.56
  投资支付的现金0--10,200,000
  取得子公司及其他营业单位支付的现金--0-
  投资活动现金流出小计29,543,595.4418,595,089.5916,332,745.3438,839,622.56
  投资活动产生的现金流量净额-29,504,173.44-18,555,969.59-16,266,047.38-38,811,918.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金160,000---
  其中:子公司吸收少数股东投资收到的现金160,000---
  取得借款收到的现金973,887,714.67573,556,493.11537,175,829.861,091,831,659.5
  收到其他与筹资活动有关的现金132,412,000128,722,000128,232,070.75244,000,000
  筹资活动现金流入小计1,106,459,714.67702,278,493.11665,407,900.611,335,831,659.5
  偿还债务支付的现金888,525,222.22528,744,595.08423,700,671.81,204,074,220.57
  分配股利、利润或偿付利息支付的现金23,688,868.9315,650,514.045,934,078.5533,554,127.61
  其中:子公司支付给少数股东的股利、利润1,125,0001,125,000-900,000
  支付其他与筹资活动有关的现金179,044,648.2123,930,978.8979,290,097.07147,749,040.32
  筹资活动现金流出小计1,091,258,739.35668,326,088.01508,924,847.421,385,377,388.5
  筹资活动产生的现金流量净额15,200,975.3233,952,405.1156,483,053.19-49,545,729
四、汇率变动对现金及现金等价物的影响-8,607.45-1,313.63-449.4814,517.11
五、现金及现金等价物净增加额-42,967,228.88-39,732,712.64-39,724,149.46-87,904,478.64
  加:期初现金及现金等价物余额266,066,794.14266,066,794.14266,065,780.6353,971,272.78
  期末现金及现金等价物余额223,099,565.26226,334,081.5226,341,631.14266,066,794.14
补充资料:
  净利润-31,984,041.57-41,240,982.63
  资产减值准备-3,178,620.46-2,661,266.95
  固定资产和投资性房地产折旧-24,447,826.14-53,355,065.6
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-24,447,826.14-53,355,065.6
  无形资产摊销-2,136,935.65-4,273,964.87
  长期待摊费用摊销-1,021,958.47-1,902,161.65
  处置固定资产、无形资产和其他长期资产的损失--6,663.05-59,174.03
  固定资产报废损失-6,749.8-143,899.02
  财务费用-15,078,522.87-39,366,353.31
  投资损失-350,293.32-1,312,375.05
  递延所得税--243,398.68--647,375.14
  其中:递延所得税资产减少--312,702.18--645,612.48
    递延所得税负债增加-69,303.5--1,762.66
  存货的减少-15,480,715.17-33,943,042
  经营性应收项目的减少--98,242,876.29-9,140,872.41
  经营性应付项目的增加--55,076,867.62--196,052,077.13
  现金的期末余额-226,334,081.5-266,066,794.14
  减:现金的期初余额-266,066,794.14-353,971,272.78
  现金及现金等价物的净增加额--39,732,712.64--87,904,478.64
公告日期2025-10-312025-08-272025-04-302025-04-15
审计意见(境内)标准无保留意见
TOP↑